Durvalumab in Small-Cell Lung Cancer

被引:0
作者
Petrelli, Fausto [1 ]
Dottorini, Lorenzo [1 ]
Ghidini, Antonio [2 ]
机构
[1] Azienda Socio Sanitaria Terr Bergamo Ovest, Treviglio, Italy
[2] Casa Cura Igea, Milan, Italy
关键词
D O I
10.1056/NEJMc2414036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2385 / 2386
页数:2
相关论文
共 8 条
[1]   High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538 [J].
Bogart, Jeffrey ;
Wang, Xiaofei ;
Masters, Gregory ;
Gao, Junheng ;
Komaki, Ritsuko ;
Gaspar, Laurie E. ;
Heymach, John ;
Bonner, James ;
Kuzma, Charles ;
Waqar, Saiama ;
Petty, William ;
Stinchcombe, Thomas E. ;
Bradley, Jeffrey D. ;
Vokes, Everett .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13) :2394-+
[2]   Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer [J].
Cheng, Ying ;
Spigel, David R. ;
Cho, Byoung Chul ;
Laktionov, Konstantin K. ;
Fang, Jian ;
Chen, Yuanbin ;
Zenke, Yoshitaka ;
Lee, Ki Hyeong ;
Wang, Qiming ;
Navarro, Alejandro ;
Bernabe, Reyes ;
Buchmeier, Eva Lotte ;
Chang, John Wen-Cheng ;
Shiraishi, Yoshimasa ;
Goksu, Sema Sezgin ;
Badzio, Andrzej ;
Shi, Anhui ;
Daniel, Davey B. ;
Hoa, Nguyen Thi Thai ;
Zemanova, Milada ;
Mann, Helen ;
Gowda, Hema ;
Jiang, Haiyi ;
Senan, Suresh .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (14) :1313-1327
[3]   Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial [J].
Faivre-Finn, Corinne ;
Snee, Michael ;
Ashcroft, Linda ;
Appel, Wiebke ;
Barlesi, Fabrice ;
Bhatnagar, Adityanarayan ;
Bezjak, Andrea ;
Cardenal, Felipe ;
Fournel, Pierre ;
Harden, Susan ;
Le Pechoux, Cecile ;
McMenemin, Rhona ;
Mohammed, Nazia ;
O'Brien, Mary ;
Pantarotto, Jason ;
Surmont, Veerle ;
Van Meerbeeck, Jan P. ;
Woll, Penella J. ;
Lorigan, Paul ;
Blackhall, Fiona .
LANCET ONCOLOGY, 2017, 18 (08) :1116-1125
[4]  
Gronberg BHH, 2023, J CLIN ONCOL, V41
[5]  
Gronberg BH, 2021, LANCET ONCOL, V22, P321, DOI 10.1016/S1470-2045(20)30742-7
[6]   New strategies for patients with limited-stage small-cell lung cancer [J].
Schneiders, Famke L. ;
Senan, Suresh .
LANCET RESPIRATORY MEDICINE, 2024, 12 (10) :748-750
[7]  
Senan S., 2024, Ann Oncol, V35, pS1267
[8]   Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide [J].
Turrisi, AT ;
Kim, K ;
Blum, R ;
Sause, WT ;
Livingston, RB ;
Komaki, R ;
Wagner, H ;
Aisner, S ;
Johnson, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :265-271